higher-triglyceride-to-hdl-ratio-linked-to-elevated-ldl-in-underweight-women
Higher Triglyceride to HDL Ratio Linked to Elevated LDL in Underweight Women

Higher Triglyceride to HDL Ratio Linked to Elevated LDL in Underweight Women

In a five-year repeated cross-sectional study of underweight women undergoing occupational health examinations, researchers observed that a higher triglyceride-to-high-density lipoprotein cholesterol ratio was associated with modestly elevated levels of low-density lipoprotein cholesterol and fasting blood glucose. The investigation evaluated routine health examination records from working women aged 20 to 49 years with a body mass index under 18.5 kilograms per square meter, tracking how variation in this specific lipid ratio corresponded to broader metabolic indicators within a demographic group generally perceived to have minimal metabolic risk.

The underlying research question focused on metabolic variability among individuals with low body mass index values. Although underweight women are frequently presumed to possess uniformly favorable metabolic profiles because of their low body weight, clinical evidence indicates that low weight alone does not guarantee optimal metabolic health. To investigate whether routine laboratory parameters reflect subtle metabolic differences in this population, the study examined the relationship between the triglyceride-to-high-density lipoprotein cholesterol ratio and key glycemic and lipid markers measured during regular annual workplace screenings.

The study sample comprised 650 health checkup records collected over a five-year period from female workers who met the inclusion criteria. Participants were required to have a body mass index below 18.5 kilograms per square meter and concurrently measured, positive values for both serum triglycerides and high-density lipoprotein cholesterol. Within this cohort of records, the mean participant age was 34.8 years with a standard deviation of 7.8 years, while the mean body mass index was 17.4 kilograms per square meter with a standard deviation of 0.9 kilograms per square meter. The median triglyceride-to-high-density lipoprotein cholesterol ratio across the records stood at 0.67, spanning an interquartile range from 0.49 to 0.95.

Data collection relied on standard workplace screening documentation, which imposed specific operational boundaries on the dataset. Serum triglyceride measurements were derived from the conventional clinical triglyceride field; although separately recorded postprandial triglyceride values were excluded, the authors noted that some nonfasting measurements may still have been present in the primary field. Fasting blood glucose values were extracted strictly from dedicated fasting glucose records. Furthermore, because individual patient identifiers were omitted from the dataset, the investigators could not track unique individuals across consecutive fiscal years or isolate repeat examinations by the same participants.

To assess these relationships, the researchers utilized linear regression models to calculate both unadjusted crude estimates and multivariable models adjusted for participant age, body mass index, and fiscal year. Statistical estimates were calculated and reported per doubling of the triglyceride-to-high-density lipoprotein cholesterol ratio. This mathematical scaling allowed the research team to evaluate incremental shifts in circulating markers across the observed distribution of lipid ratios, testing whether progressively elevated ratios corresponded to shifts in standard cardiometabolic laboratory values.

The primary regression analyses demonstrated significant positive associations between the lipid ratio and both target biomarkers. Each doubling of the triglyceride-to-high-density lipoprotein cholesterol ratio was associated with a 5.53 milligrams per deciliter higher concentration of low-density lipoprotein cholesterol, with a 95 percent confidence interval ranging from 2.49 to 8.57 milligrams per deciliter and a significance level of p less than 0.001. In parallel, a doubling of the ratio corresponded to a 1.39 milligrams per deciliter increase in fasting blood glucose, supported by a 95 percent confidence interval of 0.49 to 2.29 milligrams per deciliter and a p-value of 0.003. Both associations remained statistically significant following formal correction for multiple testing comparisons.

Robustness analyses indicated that these observed relationships were largely stable across several model specifications. The estimated associations changed very little when the investigators excluded individuals who were actively using relevant medications from the analytical sample. Similarly, incorporating lifestyle covariates—specifically self-reported cigarette smoking status, the frequency of alcohol consumption, and participation in regular physical exercise—did not materially attenuate the observed effect sizes. In addition, analyses stratifying the dataset by individual fiscal years showed no detectable interaction between fiscal year and the primary biomarker associations.

To evaluate potential threshold effects or curved relationships, the investigators modeled nonlinear patterns using restricted cubic splines. When the analysis was trimmed to restrict data points to the 1st through the 99th percentile range of the lipid ratio, the overall spline association for low-density lipoprotein cholesterol remained statistically significant across the distribution. Conversely, the spline association between the lipid ratio and fasting glucose lost statistical significance following this percentile trimming, yielding a p-value of 0.114 and indicating a less robust relationship across the central range of observations.

The authors concluded that while higher triglyceride-to-high-density lipoprotein cholesterol ratios correspond to measurable differences in metabolic indicators among underweight women, the absolute magnitude of these changes remains small. Because the study utilized a repeated cross-sectional architecture without unique individual identification, causal pathways cannot be established, and potential exposure misclassification in nonfasting lipid measures further restricts direct clinical application. Consequently, the authors emphasized that although the findings document physiological variation within the underweight classification, they do not establish that the ratio provides immediate utility as a clinical screening tool.

Subject of Research: Association of triglyceride-to-HDL cholesterol ratio with metabolic markers in underweight women

Article Title: Association of the triglyceride-to-HDL cholesterol ratio with metabolic markers among underweight women undergoing occupational health checkups: a five-year repeated cross-sectional study

Article References: Asakawa, T. (2026). Association of the triglyceride-to-HDL cholesterol ratio with metabolic markers among underweight women undergoing occupational health checkups: a five-year repeated cross-sectional study. Lipids in Health and Disease. https://doi.org/10.1186/s12944-026-03073-3

Image Credits: AI Generated

DOI: 10.1186/s12944-026-03073-3

Keywords: triglyceride-to-HDL ratio, underweight women, metabolic markers, LDL cholesterol, fasting glucose, occupational health, cross-sectional study, lipid profiles, body mass index, linear regression, restricted cubic splines, lifestyle factors, health checkups, metabolic risk, high-density lipoprotein, serum lipids